Fox Run Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.22M | Buy |
9,055
+5,261
| +139% | +$1.31M | 0.39% | 10 |
|
|
2025
Q4 | $1.04M | Sell |
3,794
-1,396
| -27% | -$382K | 0.16% | 197 |
|
|
2025
Q3 | $1.36M | Sell |
5,190
-2,504
| -33% | -$609K | 0.21% | 115 |
|
|
2025
Q2 | $1.68M | Buy |
+7,694
| New | +$1.64M | 0.28% | 58 |
|
|
2024
Q4 | – | Sell |
-1,112
| Closed | -$334K | – | 1215 |
|
|
2024
Q3 | $334K | Sell |
1,112
-2,112
| -66% | -$647K | 0.07% | 502 |
|
|
2024
Q2 | $1.06M | Buy |
+3,224
| New | +$1.14M | 0.2% | 161 |
|
|
2023
Q4 | – | Sell |
-2,470
| Closed | -$927K | – | 1057 |
|
|
2023
Q3 | $927K | Buy |
+2,470
| New | +$955K | 0.27% | 88 |
|
|
2023
Q1 | – | Sell |
-1,523
| Closed | -$358K | – | 961 |
|
|
2022
Q4 | $358K | Buy |
1,523
+613
| +67% | +$145K | 0.14% | 282 |
|
|
2022
Q3 | $224K | Buy |
+910
| New | +$277K | 0.09% | 447 |
|
|
2021
Q4 | – | Sell |
-530
| Closed | -$225K | – | 731 |
|
|
2021
Q3 | $225K | Buy |
+530
| New | +$223K | 0.14% | 341 |
|
|
2019
Q4 | – | Sell |
-5,136
| Closed | -$728K | – | 549 |
|
|
2019
Q3 | $728K | Buy |
+5,136
| New | +$707K | 0.66% | 7 |
|
|
2019
Q1 | – | Sell |
-4,385
| Closed | -$430K | – | 719 |
|
|
2018
Q4 | $430K | Buy |
+4,385
| New | +$476K | 0.23% | 153 |
|
|
2017
Q4 | – | Sell |
-5,200
| Closed | -$501K | – | 917 |
|
|
2017
Q3 | $501K | Sell |
5,200
-4,100
| -44% | -$371K | 0.14% | 297 |
|
|
2017
Q2 | $879K | Buy |
+9,300
| New | +$855K | 0.3% | 59 |
|
Other funds holding WST
VCM
VPM
GIM
